✨ Unlock Data Exports And Disclosure Access.Start Your 30-Day Free Trial Today →

Astellas Pharma Inc

Common Name
Astellas Pharma
Country
Japan
Sector
Healthcare
Industry
Drug Manufacturers - General
Employees
13,643
Ticker
4503
Exchange
Japan Exchange Group
Description
Astellas Pharma Inc. is a Japanese multinational pharmaceutical company formed in 2005 through the merger of Yamanouchi Pharmaceutical Co., Ltd. and Fujisawa Pharmaceutical Co., Ltd. It discovers, dev...

Astellas Pharma's Board and Committee Meetings Data

Explore Astellas Pharma's board and committee governance data, including meeting counts and attendance rates for the board, audit committee, compensation/remuneration committee, and nomination committee.

Metric2026
Board Meeting Count
11a
Board Meeting Attendance Rate
100%a
Audit Committee Meetings
19a
Audit Committee Meeting Attendance Rate
100%a
Compensation/Remuneration Committee Meetings
8a
Compensation/Remuneration Committee Meeting Attendance Rate
100%a
Nomination Committee Meetings
10a
Nomination Committee Meeting Attendance Rate
98.21%a
Usage Policy

You are welcome to quote or reference individual data points from this page, provided you include the following attribution with a visible, clickable link to this page: "Source: Tracenable, the global reference for ESG data"

Bulk collection, scraping, resale, or redistribution of data across multiple company profiles is not permitted without our prior written permission. For more information, see our General Terms and Conditions.

Verified Sources Behind Astellas Pharma’s Board and Committee Meetings Data

Every figure on this dashboard has a transparent audit trail. With Tracenable, each data point is traceable back to its original source, viewable directly inside our platform.

a. Astellas Pharma's Securities Report 2025